New York · 2025 Regular Session · Bill

S 9497: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

In committee Last action June 1, 2026: SUBSTITUTED BY A1428

Plain-language summary

S 9497 is a bill introduced in the New York Senate on March 18, 2026. According to its official title, it concerns: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug. Primary sponsor: Nathalia Fernández (Democratic). Most recent recorded action (June 1, 2026): SUBSTITUTED BY A1428.

Sponsors

Primary sponsor: Nathalia Fernández (Democratic).